Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans

Journal of Clinical Investigation

Volumn 119, Issue 5, 2009, Pages 1322-1334

  Stanhope, Kimber L ^a   Schwarz, Jean Marc ^b,c   Keim, Nancy L ^d   Griffen, Steven C ^a   Bremer, Andrew A ^a   Graham, James L ^a   Hatcher, Bonnie ^a   Cox, Chad L ^a   Dyachenko, Artem ^b   Zhang, Wei ^a   McGahan, John P ^e   Seibert, Anthony ^e   Krauss, Ronald M ^f   Chiu, Sally ^f   Schaefer, Ernst J ^g   Ai, Masumi ^g   Otokozawa, Seiko ^g   Nakajima, Katsuyuki ^g,h   Nakano, Takamitsu ^h   Beysen, Carine ⁱ   Hellerstein, Marc K ^i,j   Berglund, Lars ^a,k   Havel, Peter J ^a   more..

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Touro University California   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d U S DEPARTMENT OF AGRICULTURE   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f CHILDREN S HOSPITAL OAKLAND RESEARCH INSTITUTE   (United States)

^g TUFTS UNIVERSITY   (United States)

^h OTSUKA PHARMACEUTICAL CO LTD   (Japan)

ⁱ KINEMED INC   (United States)

^j UNIVERSITY OF CALIFORNIA   (United States)

^k VA NORTHERN CALIFORNIA HEALTH CARE SYSTEM   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B; CHOLESTEROL; FRUCTOSE; GLUCOSE; INSULIN; LIPID; LIPOPROTEIN; OXIDIZED LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BEVERAGE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DYSLIPIDEMIA; ENERGY; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE INTAKE; HUMAN; INSULIN BLOOD LEVEL; INSULIN SENSITIVITY; INTRAABDOMINAL FAT; LIPID METABOLISM; LIPOGENESIS; LIPOPROTEIN BLOOD LEVEL; MALE; OBESITY; POSTPRANDIAL STATE; PRIORITY JOURNAL; SUGAR INTAKE; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT GAIN; BIOLOGICAL MODEL; BLOOD; BODY WEIGHT; CALORIC INTAKE; DOUBLE BLIND PROCEDURE; EATING; GENE EXPRESSION; GENETICS; HISTOLOGY; INSULIN RESISTANCE; LIVER; METABOLISM; MIDDLE AGED; PHYSIOLOGY; SEXUAL DEVELOPMENT; SUBCUTANEOUS FAT;

BEVERAGES; BLOOD GLUCOSE; BODY WEIGHT; DIETARY SUCROSE; DOUBLE-BLIND METHOD; EATING; ENERGY INTAKE; FEMALE; FRUCTOSE; GENE EXPRESSION; GLUCOSE; HUMANS; INSULIN; INSULIN RESISTANCE; INTRA-ABDOMINAL FAT; LIPID METABOLISM; LIPIDS; LIPOPROTEINS; LIVER; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; OBESITY; OVERWEIGHT; SEX CHARACTERISTICS; SUBCUTANEOUS FAT; TRIGLYCERIDES;

EID: 66449093225     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI37385     Document Type: Article

References (86)

1. Bizeau, M.E., and Pagliassotti, M.J. 2005. Hepatic adaptations to sucrose and fructose. Metabolism. 54:1189-1201.
2. Havel, P.J. 2005. Dietary fructose: implications for dysregulation of energy homeostasis and lipid/carbohydrate metabolism. Nutr. Rev. 63:133-157.
3. Le, K.A., and Tappy, L. 2006. Metabolic effects of fructose. Curr. Opin. Clin. Nutr. Metab. Care. 9:469-475.
4. Wei, Y., Wang, D., Topczewski, F., and Pagliassotti, M.J. 2007. Fructose-mediated stress signaling in the liver: implications for hepatic insulin resistance. J. Nutr. Biochem. 18:1-9.
5. Beysen, C., et al. 2007. Whole-body glycolysis measured by the deuterated-glucose disposal test correlates highly with insulin resistance in vivo. Diabetes Care. 30:1143-1149.
6. Bantle, J.P., Swanson, J.E., Thomas, W., and Laine, D.C. 1992. Metabolic effects of dietary fructose in diabetic subjects. Diabetes Care. 15:1468-1476.
7. Crapo, P.A., and Kolterman, O.G. 1984. The metabolic effects of 2-week fructose feeding in normal subjects. Am. J. Clin. Nutr. 39:525-534.
8. Koivisto, V.A., and Yki-Jarvinen, H. 1993. Fructose and insulin sensitivity in patients with type 2 diabetes. J. Intern. Med. 233:145-153.
9. Reiser, S., Bickard, M.C., Hallfrisch, J., Michaelis, O.E., 4th, and Prather, E.S. 1981. Blood lipids and their distribution in lipoproteins in hyperinsulinemic subjects fed three different levels of sucrose. J. Nutr. 111:1045-1057.
10. Swanson, J.E., Laine, D.C., Thomas, W., and Bantle, J.P. 1992. Metabolic effects of dietary fructose in healthy subjects. Am. J. Clin. Nutr. 55:851-856.
11. Swarbrick, M.M., et al. 2008. Consumption of fructose-sweetened beverages for 10 weeks increases postprandial triacylglycerol and apolipoprotein-B concentrations in overweight and obese women. Br. J. Nutr. 100:947-952.
12. Turner, J.L., Bierman, E.L., Brunzell, J.D., and Chait, A. 1979. Effect of dietary fructose on triglyceride transport and glucoregulatory hormones in hypertriglyceridemic men. Am. J. Clin. Nutr. 32:1043-1050.
13. Bantle, J.P., Raatz, S.K., Thomas, W., and Georgopoulos, A. 2000. Effects of dietary fructose on plasma lipids in healthy subjects. Am. J. Clin. Nutr. 72:1128-1134.
14. Crapo, P.A., Kolterman, O.G., and Henry, R.R. 1986. Metabolic consequence of two-week fructose feeding in diabetic subjects. Diabetes Care. 9:111-119.
15. Hallfrisch, J., et al. 1983. Effects of dietary fructose on plasma glucose and hormone responses in normal and hyperinsulinemic men. J. Nutr. 113:1819-1826.
16. Herman, R.H., Zakim, D., and Stifel, F.B. 1970. Effect of diet on lipid metabolism in experimental animals and man. Fed. Proc. 29:1302-1307.
17. Le, K.A., et al. 2006. A 4-wk high-fructose diet alters lipid metabolism without affecting insulin sensitivity or ectopic lipids in healthy humans. Am. J. Clin. Nutr. 84:1374-1379.
18. Reiser, S., et al. 1989. Day-long glucose, insulin, and fructose responses of hyperinsulinemic and nonhyperinsulinemic men adapted to diets containing either fructose or high-amylose cornstarch. Am. J. Clin. Nutr. 50:1008-1014.
19. Stanhope, K.L., et al. 2008. Twenty-four-hour endocrine and metabolic profiles following consumption of high-fructose corn syrup-, sucrose-, fructose-, and glucose-sweetened beverages with meals. Am. J. Clin. Nutr. 87:1194-1203.
20. Nabeno, Y., Fukuchi, Y., Matsutani, Y., and Naito, M. 2007. Influence of aging and menopause on postprandial lipoprotein responses in healthy adult women. J. Atheroscler. Thromb. 14:142-150.
21. Kolovou, G.D., et al. 2004. The influence of natural menopause on postprandial lipemia in heterozygotes for familial hypercholesterolemia. J. Womens Health. (Larchmt.) 13:1119-1126.
22. Kolovou, G.D., and Bilianou, H.G. 2008. Influence of aging and menopause on lipids and lipoproteins in women. Angiology. 59:54S-57S.
23. Mayes, P.A. 1993. Intermediary metabolism of fructose. Am. J. Clin. Nutr. 58:754S-765S.
24. Matsuzaka, T., et al. 2004. Insulin-independent induction of sterol regulatory element-binding protein-1c expression in the livers of streptozotocin-treated mice. Diabetes. 53:560-569.
25. Nagai, Y., et al. 2002. Amelioration of high fructose-induced metabolic derangements by activation of PPARalpha. Am. J. Physiol. Endocrinol. Metab. 282:E1180-E1190.
26. Schwarz, J.M., Neese, R.A., Schakleton, C., and Hellerstein, M.K. 1993. De novo lipogenesis during fasting and oral fructose ingestion in lean and obese hyperinsulinemic subjects [abstract]. Diabetes. 42:A39.
27. Faeh, D., et al. 2005. Effect of fructose overfeeding and fish oil administration on hepatic de novo lipogenesis and insulin sensitivity in healthy men. Diabetes. 54:1907-1913.
28. McGarry, J.D. 1995. Malonyl-CoA and carnitine palmitoyltransferase I: an expanding partnership. Biochem. Soc. Trans. 23:481-485.
29. Adiels, M., et al. 2006. Overproduction of large VLDL particles is driven by increased liver fat content in man. Diabetologia. 49:755-765.
30. Olofsson, S.O., and Boren, J. 2005. Apolipoprotein B: a clinically important apolipoprotein which assembles atherogenic lipoproteins and promotes the development of atherosclerosis. J. Intern. Med. 258:395-410.
31. Adiels, M., Olofsson, S.O., Taskinen, M.R., and Boren, J. 2008. Overproduction of very low-density lipoproteins is the hallmark of the dyslipidemia in the metabolic syndrome. Arterioscler. Thromb. Vasc. Biol. 28:1225-1236.
32. Teff, K.L., et al. 2004. Dietary fructose reduces circulating insulin and leptin, attenuates postprandial suppression of ghrelin, and increases triglycerides in women. J. Clin. Endocrinol. Metab. 89:2963-2972.
33. Mead, J.R., Irvine, S.A., and Ramji, D.P. 2002. Lipoprotein lipase: structure, function, regulation, and role in disease. J. Mol. Med. 80:753-769.
34. Fried, S.K., Russell, C.D., Grauso, N.L., and Brolin, R.E. 1993. Lipoprotein lipase regulation by insulin and glucocorticoid in subcutaneous and omental adipose tissues of obese women and men. J. Clin. Invest. 92:2191-2198.
35. Bansal, S., et al. 2007. Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women. JAMA. 298:309-316.
36. Hyson, D., Rutledge, J.C., and Berglund, L. 2003. Postprandial lipemia and cardiovascular disease. Curr. Atheroscler. Rep. 5:437-444.
37. Karpe, F. 1999. Postprandial lipoprotein metabolism and atherosclerosis. J. Intern. Med. 246:341-355.
38. Lopez-Miranda, J., et al. 2006. Postprandial lipoprotein metabolism, genes and risk of cardiovascular disease. Curr. Opin. Lipidol. 17:132-138.
39. Nordestgaard, B.G., Benn, M., Schnohr, P., and Tybjaerg-Hansen, A. 2007. Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women. JAMA. 298:299-308.
40. Stalenhoef, A.F., and de Graaf, J. 2008. Association of fasting and nonfasting serum triglycerides with cardiovascular disease and the role of remnant-like lipoproteins and small dense LDL. Curr. Opin. Lipidol. 19:355-361.
41. Berneis, K.K., and Krauss, R.M. 2002. Metabolic origins and clinical significance of LDL heterogeneity. J. Lipid Res. 43:1363-1379.
42. Krauss, R.M. 2005. Dietary and genetic probes of atherogenic dyslipidemia. Arterioscler. Thromb. Vasc. Biol. 25:2265-2272.
43. Marcovina, S., and Packard, C.J. 2006. Measurement and meaning of apolipoprotein AI and apolipoprotein B plasma levels. J. Intern. Med. 259:437-446.
44. Packard, C.J. 2003. Triacylglycerol-rich lipoproteins and the generation of small, dense low-density lipoprotein. Biochem. Soc. Trans. 31:1066-1069.
45. Packard, C.J. 2006. Small dense low-density lipoprotein and its role as an independent predictor of cardiovascular disease. Curr. Opin. Lipidol. 17:412-417.
46. Rutledge, A.C., and Adeli, K. 2007. Fructose and the metabolic syndrome: pathophysiology and molecular mechanisms. Nutr. Rev. 65:S13-S23.
47. Bergman, R.N., et al. 2007. Abdominal obesity: role in the pathophysiology of metabolic disease and cardiovascular risk. Am. J. Med. 120:S3-S8; discussion S29-S32.
48. Stanhope, K.L., and Havel, P.J. 2008. Fructose consumption: potential mechanisms for its effects to increase visceral adiposity and induce dyslipidemia and insulin resistance. Curr. Opin. Lipidol. 19:16-24.
49. Morino, K., Petersen, K.F., and Shulman, G.I. 2006. Molecular mechanisms of insulin resistance in humans and their potential links with mitochondrial dysfunction. Diabetes. 55(Suppl. 2):S9-S15.
50. Seppala-Lindroos, A., et al. 2002. Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men. J. Clin. Endocrinol. Metab. 87:3023-3028.
51. Newton, A.C. 2003. Regulation of the ABC kinases by phosphorylation: protein kinase C as a paradigm. Biochem. J. 370:361-371.
52. Itani, S.I., Ruderman, N.B., Schmieder, F., and Boden, G. 2002. Lipid-induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase C, and IkappaB-alpha. Diabetes. 51:2005-2011.
53. Yu, C., et al. 2002. Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in muscle. J. Biol. Chem. 277:50230-50236.
54. Beck-Nielsen, H., Pedersen, O., and Lindskov, H.O. 1980. Impaired cellular insulin binding and insulin sensitivity induced by high-fructose feeding in normal subjects. Am. J. Clin. Nutr. 33:273-278.
55. Couchepin, C., et al. 2008. Markedly blunted metabolic effects of fructose in healthy young female subjects compared with male subjects. Diabetes Care. 31:1254-1256.
56. Gibbons, G.F., Islam, K., and Pease, R.J. 2000. Mobilisation of triacylglycerol stores. Biochim. Biophys. Acta. 1483:37-57.
57. Toth, M.J., and Tchernof, A. 2000. Lipid metabolism in the elderly. Eur. J. Clin. Nutr. 54(Suppl. 3):S121-S125.
58. Guthrie, J.F., and Morton, J.F. 2000. Food sources of added sweeteners in the diets of Americans. J. Am. Diet Assoc. 100:43-51.
59. Mundt, C.A., et al. 2006. Relationships of activity and sugar drink intake on fat mass development in youths. Med. Sci. Sports Exerc. 38:1245-1254.
60. Storey, M.L., Forshee, R.A., and Anderson, P.A. 2006. Beverage consumption in the US population. J. Am. Diet Assoc. 106:1992- 2000.
61. Striegel-Moore, R.H., et al. 2006. Correlates of beverage intake in adolescent girls: the National Heart, Lung, and Blood Institute Growth and Health Study. J. Pediatr. 148:183-187.
62. van der Horst, K., et al. 2007. Perceived parenting style and practices and the consumption of sugar-sweetened beverages by adolescents. Health Educ. Res. 22:295-304.
63. West, D.S., et al. 2006. Self-reported sugar-sweetened beverage intake among college students. Obesity (Silver Spring). 14:1825-1831.
64. Matsuura, E., Hughes, G.R., and Khamashta, M.A. 2008. Oxidation of LDL and its clinical implication. Autoimmun. Rev. 7:558-566.
65. Nakajima, K., Nakano, T., and Tanaka, A. 2006. The oxidative modification hypothesis of atherosclerosis: the comparison of atherogenic effects on oxidized LDL and remnant lipoproteins in plasma. Clin. Chim. Acta. 367:36-47.
66. Walldius, G., and Jungner, I. 2006. The apoB/apoA-I ratio: a strong, new risk factor for cardiovascular disease and a target for lipid-lowering therapy - a review of the evidence. J. Intern. Med. 259:493-519.
67. Mifflin, M.D., et al. 1990. A new predictive equation for resting energy expenditure in healthy individuals. Am. J. Clin. Nutr. 51:241-247.
68. Keim, N.L., Stern, J.S., and Havel, P.J. 1998. Relation between circulating leptin concentrations and appetite during a prolonged, moderate energy deficit in women. Am. J. Clin. Nutr. 68:794-801.
69. Conway, J.M., Ingwersen, L.A., Vinyard, B.T., and Moshfegh, A.J. 2003. Effectiveness of the US Department of Agriculture 5-step multiple-pass method in assessing food intake in obese and nonobese women. Am. J. Clin. Nutr. 77:1171-1178.
70. Mangravite, L.M., Dawson, K., Davis, R.R., Gregg, J.P., and Krauss, R.M. 2007. Fatty acid desaturase regulation in adipose tissue by dietary composition is independent of weight loss and is correlated with the plasma triacylglycerol response. Am. J. Clin. Nutr. 86:759-767.
71. Havel, P.J., Townsend, R., Chaump, L., and Teff, K. 1999. High-fat meals reduce 24-h circulating leptin concentrations in women. Diabetes. 48:334-341.
72. Lichtenstein, A.H., et al. 1990. Comparison of deuterated leucine, valine, and lysine in the measurement of human apolipoprotein A-I and B-100 kinetics. J. Lipid Res. 31:1693-1701.
73. Karpe, F., Steiner, G., Uffelman, K., Olivecrona, T., and Hamsten, A. 1994. Postprandial lipoproteins and progression of coronary atherosclerosis. Atherosclerosis. 106:83-97.
74. Hellerstein, M.K., et al. 1991. Measurement of de novo hepatic lipogenesis in humans using stable isotopes. J. Clin. Invest. 87:1841-1852.
75. Imamura, S., et al. 2007. A novel method for measuring human hepatic lipase activity in postheparin plasma. J. Lipid Res. 48:453-457.
76. Williams, K.V., et al. 2003. Glucose transport and phosphorylation in skeletal muscle in obesity: insight from a muscle-specific positron emission tomography model. J. Clin. Endocrinol. Metab. 88:1271-1279.
77. Hirano, T., Ito, Y., and Yoshino, G. 2005. Measurement of small dense low-density lipoprotein particles. J. Atheroscler. Thromb. 12:67-72.
78. Hirano, T., Ito, Y., Saegusa, H., and Yoshino, G. 2003. A novel and simple method for quantification of small, dense LDL. J. Lipid Res. 44:2193-2201.
79. Okada, M., Matsui, H., Ito, Y., Fujiwara, A., and Inano, K. 1998. Low-density lipoprotein cholesterol can be chemically measured: a new superior method. J. Lab. Clin. Med. 132:195-201.
80. Sakaue, T., et al. 2000. Reactions of direct LDL-cholesterol assays with pure LDL fraction and IDL: comparison of three homogeneous methods. Clin. Chim. Acta. 295:97-106.
81. Marcoux, C., et al. 1998. Plasma remnant-like particle lipid and apolipoprotein levels in normolipidemic and hyperlipidemic subjects. Atherosclerosis. 139:161-171.
82. Nakajima, K., et al. 1994. A new approach for the detection of type III hyperlipoproteinemia by RLP-cholesterol assay. J. Atheroscler. Thromb. 1:30-36.
83. Al-Daghri, N.M., Al-Attas, O.S., Al-Rubeaan, K., and Sallam, R. 2008. Adipocytokine profile of type 2 diabetics in metabolic syndrome as defined by various criteria. Diabetes Metab. Res. Rev. 24:52-58.
84. Genuth, S., et al. 2003. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care. 26:3160-3167.
85. Samuel, V.T., et al. 2007. Inhibition of protein kinase Cepsilon prevents hepatic insulin resistance in nonalcoholic fatty liver disease. J. Clin. Invest. 117:739-745.
86. Teff, K.L., et al. 2009. Endocrine and metabolic effects of consuming fructose- and glucose-sweetened beverages with meals in obese men and women: influence of insulin resistance on plasma triglyceride responses. J. Clin. Endocrinol. Metab. doi:10.1210/jc.2008-2192.